| ¿µ¹® | hearing test | ÇÑ±Û | û·Â°Ë»ç |
|---|---|---|---|
| ¼³¸í | ±Í°¡ µé¸®´Â Á¤µµ¸¦ ÃøÁ¤ÇÏ´Â °Ë»ç. û°¢°Ë»ç¶ó°íµµ ÇÑ´Ù. ¼Ò¸®³ª ¸ñ¼Ò¸®°¡ Àß µé¸®´ÂÁöÀÇ ¿©ºÎ µî û°¢ÀÇ ¿¹¹ÎÇÑ Á¤µµ¸¦ ÃøÁ¤ÇÏ´Â ÀÏÀÌ´Ù. °Ë»ç¿¡´Â û·Â°è³ª ¼Ò¸®±Á¼è µîÀÇ ±â±¸¿¡ ÀÇÇØ¼ ¾ò´Â À½¿ø, Áï ¼øÀ½À» »ç¿ëÇϸç, »ç¶÷ÀÇ ¸ñ¼Ò¸®³ª ½Ã°è¼Ò¸® µîµµ À½¿øÀ¸·Î »ç¿ëµÈ´Ù. ¶Ç À½ÆÄ°¡ ÀüÆÄµÇ´Â ¸ÅÁú¿¡ µû¶ó ±âµµ û·Â°Ë»ç¿Í °ñµµ û·Â°Ë»ç·Î ±¸º°µÇ±âµµ ÇÑ´Ù. °Ë»çÀÇ ³»¿ëÀ¸·Î´Â û°¢ÀÇ »óÇÏÀ½°è³ª ÃÖ¼Ò °¡Ã»¹®ÅΰªÀÇ °Ë»ç¸¦ ºñ·ÔÇÏ¿©, ÃæºÐÈ÷ µé¸®´Â ¼Ò¸®¸¦ »ç¿ëÇÏ¿© ±×°ÍÀÌ µé¸®´Â »óŸ¦ Á¶»çÇÏ´Â ¹®Åΰª°Ë»ç(¼Ò¸®ÀÇ Å©±â¿Í »óÅÂÀÇ °Ë»ç, ¼¼±âÀÇ ÆÇº°¿ª°Ë»ç µî) ¿Ü¿¡ À½ÇâÀÚ±ØÀÇ ¹ÝÀÀÀ¸·ÎºÎÅÍ Å¸°¢ÀûÀ¸·Î Á¶»çÇÏ´Â ¹æ¹ýµµ ÀÖÀ¸¸ç, À̰ÍÀº ÁÖ·Î °«³¾Æ±â³ª Á¤½Åº´È¯ÀÚ¿¡ ´ëÇÏ¿© »ç¿ëµÈ´Ù. ÁַΠû·Â°è°¡ »ç¿ëµÇ°í, û·ÂÀº µ¥½Ãº§(dB)·Î Ç¥½ÃµÈ´Ù. Á¤»óÀÎÀº 0dBÀ̰í, ³Ã»ÀÚÀϼö·Ï ±× ¼ö°¡ Ä¿Áö¸ç, 60dBÀÌ»óÀº »ó´çÈ÷ ³Ã»À̰í, 80dB ÀÌ»óÀÌ¸é ±Í¸Ó°Å¸®ÀÌ´Ù. |
||
| ¿µ¹® | Coombs test | ÇÑ±Û | Å©¿òÁî°Ë»ç |
|---|---|---|---|
| ¼³¸í | ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü¸¦ °Ë»çÇÏ´Â ¹æ¹ý. Ç×ü¶õ ƯÁ¤ÇÑ ¹°Áú¿¡ ºÎÂøµÇ¾î ±× ¹°ÁúÀÇ ÀÛ¿ëÀ» ¾ïÁ¦Çϰí, ¶Ç´Â ±× ¹°ÁúÀ» ÆÄ±«ÇÏ´Â °ÍÀ¸·Î B-¸²ÇÁ±¸¶ó´Â ¸é¿ªÀ» ´ã´çÇÏ´Â ¼¼Æ÷¿¡ ÀÇÇØ¼ ¸¸µé¾îÁø´Ù. ÀÌ Å©¿òÁî°Ë»ç¿¡´Â Á÷Á¢Å©¿òÁî°Ë»ç¿Í °£Á¢Å©¿òÁî°Ë»çÀÇ µÎ °¡Áö°¡ Àִµ¥ Á÷Á¢ Å©¿òÁî°Ë»ç´Â ¸ö¼ÓÀÇ ÀûÇ÷±¸¿¡ Á÷Á¢ ºÎÂøµÇ¾î ÀÖ´Â Ç×ü¸¦ °Ë»çÇÏ´Â ¹æ¹ýÀÌ´Ù. äÃëÇÑ Ç÷¾×À» ÀûÇ÷±¸¸¦ ¾ò¾î¼ »ç¶÷ÀÇ Ç×ü¿¡ ´ëÇÑ Ç×ü(»ç¶÷ÀÇ Ç×ü¿¡ ƯÁ¤ÇÏ°Ô ºÎÂøÀÌ µÇ´Â Ç×ü)¸¦ ¹ÝÀÀ½Ã۸é, ¸¸¾à ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ ºÎÂøµÇ¾î ÀÖ´Â ÀûÇ÷±¸¶ó¸é »ç¶÷ÀÇ Ç×ü¿¡ ´ëÇÑ Ç×ü°¡, ÀÛ¿ëÇÏ¿© ħ° ¹ÝÀÀÀÌ ÀϾ°Ô µÇ°í Ç×ü°¡ ºÎÂøµÇ¾î ÀÖÁö ¾Ê´Â ÀûÇ÷±¸ÀÌ¸é ¹ÝÀÀÀÌ ÀϾÁö ¾Ê´Â °ÍÀ» ÀÌ¿ëÇÑ´Ù. °£Á¢Å©¿òÁî°Ë»ç´Â Ç÷Àå¼Ó¿¡ Á¸ÀçÇÏ´Â ÀûÇ÷±¸¿Í ºÎÂøµÇ¾î ÀÖÁö ¾ÊÀº Ç×ü¸¦ ã¾Æ³»´Â ½ÃÇèÀ¸·Î Ç÷ÀåÀ» äÃëÇØ¼ ´Ù¸¥ »ç¶÷ÀÇ ÀûÇ÷±¸¿Í ¹ÝÀÀÀ» ½ÃŰ°í ¿ª½Ã Ç×ü¿¡ ´ëÇÑ Ç×ü¸¦ ¹ÝÀÀ½ÃÄÑ Ä§°¹ÝÀÀÀ» °üÂûÇØ¼ ±× Ç×ü¸¦ ã¾Æ³»´Â ¹æ¹ýÀÌ´Ù. |
||
| ¿µ¹® | tuberculin test | ÇÑ±Û | Æ©º£¸£Ä𸰰˻ç |
|---|---|---|---|
| ¼³¸í | ¸¹Àº ¼·Î ´Ù¸¥ ÇüÅÂÀÇ Æ©º£¸£Ä𸰰ú ´Ù¾çÇÑ Åõ¿©¹æ¹ý¿¡ ÀÇÇÑ ¸ðµç Á¾·ùÀÇ °áÇÙ ÇǺΰ˻ç¹ý. ÇöÀç Ç¥ÁØ ½ÃÇè¹ýÀ¸·Î µÇ¾îÀÖ´Â °¡Àå ½Åºù¼ºÀÖ´Â °Ë»ç·Î´Â PPD¸¦ Çdz»ÁÖ»çÇÏ´Â ¹æ¹ý¸ÁÅä¿ì °Ë»çÀÌ´Ù. Çdz»ÁÖ»çÈÄ 48~72½Ã°£ ÈÄ¿¡ ÁÖ»çºÎÀ§¿¡ Á÷°æ 10mmÀÌ»óÀ¸·Î º¸À̸ç, ¸¸Á®Áö´Â È«¹Ý°ú °æÈ°¡ ³ªÅ¸³ª¸é ¾ç¼ºÀÌ´Ù. ¼ºÀο¡°Ô´Â ÀϹÝÀûÀ¸·Î Áß°£ °µµÀÇ Æ©º£¸£Äð¸°(5Tu)À» »ç¿ëÇϸç, ¾ç¼º¹ÝÀÀÀÌ ³ªÅ¸³ª¸é °áÇÙ±Õ¿¡ ÀÌÀü¿¡ °¨¿°µÇ¾ú°Å³ª ÇöÀç °¨¿°µÇ¾î ÀÖ´Ù´Â È®Á¤Àû Áø´ÜÀÌ µÈ´Ù. À½¼º¹ÝÀÀÀº °áÇÙÀÌ ¾ø°Å³ª, ½ÉÇÑ °áÇÙ°¨¿°¿¡ ÀÇÇÑ ÇǺξ˷¹¸£±â°¡ ÀÖÀ» °æ¿ì, ¶Ç´Â ¸é¿ª¾ïÁ¦¸¦ ³ªÅ¸³»´Â º´, ¿¹¸¦ µé¸é È£ÁöŲº´À̳ª »ç¸£ÄÚÀ̵åÁõ µîÀÌ ÇÕº´µÈ °æ¿ìÀÌ´Ù. |
||
| ¿µ¹® | Papanicolaou smear(test) | ÇÑ±Û | ÆÄÆÄ´ÏÄÝ·Î µµ¸»°Ë»ç |
|---|---|---|---|
| ¼³¸í | ÁÙ¿©¼ ÆËµµ¸»°Ë»ç(Pap smear)À̶ó°í ºÎ¸¥´Ù. ¿©¼ºÀÇ Àڱøñ¾ÏÀÇ ¹ß»ýÀ» ¹Ì¸® ¾Ë¾Æº¸±â À§ÇØ ½ÃÇàÇÏ´Â °Ë»ç¹ýÀ¸·Î ¹Ì±¹¿¡¼´Â ÀÌ ¹æ¹ýÀ¸·Î ÇöÀç Àڱøñ¾Ï¹ß»ý¿¡ ÀÇÇÑ »ç¸Á·üÀ» ÇöÀúÈ÷ ³·Ãß°í ÀÖ´Ù. ¹æ¹ýÀº »êºÎÀΰú¿¡¼ ½ÃÇàÇϸç, ¿©¼ºÀÇ Àڱøñ¿¡¼ ¼¼Æ÷¸¦ °¡Á®´Ù°¡ µµ¸»ÇÏ¿© Çö¹Ì°æÀ¸·Î °Ë»çÇÑ´Ù. ¿äÁîÀ½¿¡ ¿Í¼´Â Àڱøñ»Ó ¾Æ´Ï¶ó È£Èí±â³ª ºñ´¢±â µî ºÐºñ¹°À» µµ¸»ÇÏ¿© ÆÄÆÄ´ÏÄÝ·Î ¿°»öÀ» ÇÏ¿© °Ë»çÇÏ´Â °Íµµ ¿©±â¿¡ Æ÷ÇԵȴÙ. (±×¸² P-3). |
||
| ¿µ¹® | glucose tolerance test | ÇÑ±Û | Æ÷µµ´ç°ßµõ°Ë»ç |
|---|---|---|---|
| ¼³¸í | Æ÷µµ´ç°ßµõ °Ë»ç¶õ ´ç´¢º´ÀÇ Áø´Ü¿¡ »ç¿ëµÇ´Â °Ë»ç·Î ´çÀ» ü³»¿¡ Åõ¿©ÇÏ°í ½Ã°£ º°·Î Ç÷¾×À» äÃëÇÏ¿© Ç÷´çÀÇ ³óµµ¸¦ Àç¾î¼ °íÇ÷´ç ¿©ºÎ¸¦ Á¶»çÇÏ´Â °Ë»çÀÌ´Ù. ÁÖ·Î °æ±¸Æ÷µµ´ç°ßµõ°Ë»ç(oral glucose tolerance test)¸¦ ¸¹ÀÌ Çϴµ¥ À̰ÍÀº 10~16½Ã°£ÀÇ ±Ý½Ä ÈÄ¿¡ äÇ÷À» Çѹø Çѵڿ¡ µµ´ç 75gÀ» 250~300mLÀÇ ¹°¿¡ ³ì¿© 5ºÐ¿¡ °ÉÃļ ¸¶½Ã°Ô ÇÏ°í ¸Å½Ã°£ º°·Î äÇ÷À» ÇÏ¿© Ç÷´çÀÇ ³óµµ¸¦ ýũÇÑ´Ù. °øº¹½Ã¿¡ Á¤¸Æ¿¡¼ äÇ÷ÇÏ¿© ÃøÁ¤ÇÑ Ç÷´çÀÌ 140mg/dLÀÌ»óÀ̰ųª Æ÷µµ´ç°ßµõ °Ë»ç 2½Ã°£ÈÄÀÇ Ç÷´çÀÌ 200mg/dLÀÌ»óÀÏ °æ¿ì¿¡´Â ´ç´¢º´À¸·Î Áø´ÜÀ» ÇÑ´Ù. ±×·¯³ª ÀÌ °Ë»ç¸¦ ½Ç½ÃÇÒ °æ¿ì¿¡ ÁÖÀÇÇØ¾ß ÇÒ Á¡Àº °Ë»çÀü 3Àϰ£ ÇÏ·ç¿¡ 150gÀÌ»óÀÇ Åº¼öȹ°À» ¼·ÃëÇØ¾ß ÇÑ´Ù´Â °Í°ú °Ë»çµµÁß¿¡ ¿îµ¿, Èí¿¬ µîÀ» ÇÏÁö ¾Ê¾Æ¾ß ÇÑ´Ù´Â °ÍÀÌ´Ù. |
||
| IT | immunological test; immunotherapy; implantation test; individual therapy; information technology; in... |
|---|---|
| LFT | latex fixation test; latex flocculation test; left fronto-transverse [fetal position]; liver functio... |
| LTT | lactose tolerance test; leucine tolerance test; limited treadmill test; lymphocyte transformation te... |
| SAT | saliva alcohol test; satellite; serum antitrypsin; single-agent chemotherapy; slide agglutination te... |
| SRT | sedimentation rate test; simple reaction time; sinus node recovery time; sitting root test; speech r... |
| Z disc | <cell biology> Region of the sarcomere into which thin filaments are inserted. Location of _ actinin in the sarcomere. (18 Nov 1997) |
|---|---|
| fibrous ring of intervertebral disc | The ring of fibrocartilage and fibrous tissue forming the circumference of the intervertebral disc; surrounds the nucleus pulposus, which is prone to herniation when the annulus fibrosus is compromised. Synonym: annulus fibrosus disci intervertebralis, annulus fibrosus, fibrous ring of intervertebral disc, fibrous ring. (05 Mar 2000) |
| acquired sensitivity | 1. <immunology> A state of hypersensitivity induced by exposure to a particular antigen (allergen) resulting in harmful immunologic reactions on subsequent exposures, the term is usually used to refer to hypersensitivity to an environmental antigen (atopic allergy or contact dermatitis) or to drug allergy. The original meaning, now obsolete, included all states of altered immunologic reactivity, immunity as well as hypersensitivity. Gell and Coombs used the term allergic reaction to mean any harmful immunologic reaction causing tissue injury. 2. <study> The medical specialty dealing with diagnosis and treatment of allergic disorders. (18 Nov 1997) |
| analytical sensitivity | The degree of response to a change in concentration of analyte being measured in an assay; synonymous with the detection limit. (05 Mar 2000) |
| antibiotic sensitivity | Microbial susceptibility to antibiotics. See: antibiotic sensitivity test, minimal inhibitory concentration. (05 Mar 2000) |
| pacemaker sensitivity | The minimum cardiac activity required to consistently trigger a pulse generator. (05 Mar 2000) |
| relative sensitivity | The sensitivity of a medical screening test as determined by comparison with the same type of test; e.g., sensitivity of a new serological test relative to sensitivity of an established serological test. (05 Mar 2000) |
| microbial sensitivity tests | Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). (12 Dec 1998) |
| photoallergic sensitivity | See: photosensitization. (05 Mar 2000) |
| phototoxic sensitivity | See: photosensitization. (05 Mar 2000) |
| clinical sensitivity | Test positivity in disease; ability of a test to correctly identify disease. See: diagnostic sensitivity. (05 Mar 2000) |
| multiple chemical sensitivity | An acquired disorder characterised by recurrent symptoms, referable to multiple organ systems, occurring in response to demonstrable exposure to many chemically unrelated compounds at doses far below those established in the general population to cause harmful effects. No single widely accepted test of physiologic function can be shown to correlate with symptoms. (cullen mr. The worker with multiple chemical sensitivities: an overview. Occup med 1987;2(4):655-61) (12 Dec 1998) |
| contact sensitivity | Allergic response to contact with irritant, usually a hypersensitivity. (18 Nov 1997) |
| contrast sensitivity | The ability to detect sharp boundaries (stimuli) and to detect slight changes in luminance at regions without distinct contours. Psychophysical measurements of this visual function are used to evaluate visual acuity and to detect eye disease. (12 Dec 1998) |
| primaquine sensitivity | Nonimmunological inborn sensitivity to primaquine, causing haemolysis on exposure to the drug, due to deficiency of glucose-6-phosphate dehydrogenase in red cells. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|